Counteract PM 500 mg / 25 mg Oral Tablet
RxNorm 1241621
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1241621 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Counteract PM 500 mg / 25 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Acetaminophen 500 mg / diphenhydramine hydrochloride 25 mg Oral Tablet [Counteract PM]
(Atom ID: 12360329)
TMSY
Tall Man Lettering Synonym (TMSY):
Acetaminophen 500 mg / diphenhydrAMINE hydrochloride 25 mg Oral Tablet [Counteract PM]
(Atom ID: 12378208)
SY
Synonym (SY):
APAP 500 mg / Diphenhydramine Hydrochloride 25 mg Oral Tablet [Counteract PM]
(Atom ID: 4240441)
TMSY
Tall Man Lettering Synonym (TMSY):
APAP 500 mg / diphenhydrAMINE Hydrochloride 25 mg Oral Tablet [Counteract PM]
(Atom ID: 4240501)
SY
Synonym (SY):
Counteract PM (APAP 500 mg / diphenhydramine hydrochloride 25 mg) Oral Tablet
(Atom ID: 4239882)
TMSY
Tall Man Lettering Synonym (TMSY):
Counteract PM (APAP 500 mg / diphenhydrAMINE hydrochloride 25 mg) Oral Tablet
(Atom ID: 4240468)
PSN